
Automated compounding of personalized medicine
What they do: Automated compounding system using 3D printing and GMP pharmaceutical inks for personalized, on‑demand medicines
Founded: 2021 (Finland)
Founders / leadership: Charlotta Topelius (CEO) and Niklas Sandler Topelius (CTO)
Employees: ~30
Funding: Total ~USD 12.2M; Seed and debt rounds reported May 27, 2025
Personalized medicine manufacturing and pharmacy compounding
2021
Healthtech / Pharmaceutical manufacturing
≈€6.7M
Reported seed round announced May 27, 2025
≈€1.0M
Reported debt financing announced May 27, 2025
Crunchbase lists earlier seed and pre-seed rounds in 2021–2022
“Backed by institutional and public investors including Lifeline Ventures, the Pharmacy Pension Fund, EIC grant support, Business Finland loans/grants, and seed investors referenced on records”
CurifyLabs is a Finnish healthtech company developing solutions for manufacturing personalized medicines in pharmacies and hospitals. CurifyLabs is revolutionizing the way personalized medicines are created by providing innovative technology that enables automation of compounding, transforming a traditionally manual, time-intensive process into a streamlined, efficient, and accurate system.
Hardware Engineer (Mechanics & NPI) CurifyLabs HQ, Helsinki, Finland Full-time Engineering Temporarily Remote
CurifyLabs is an equal-opportunity employer committed to fostering an inclusive workplace. Join CurifyLabs and play a crucial role in empowering pharmacies to achieve greater efficiency, safety, and success.
To apply: Please submit your application and resume through our career site no later than July 2nd. We will fill the position as soon as a suitable candidate is found, so don’t wait too long!